Remove Diabetes Remove Events Remove Family Practice Remove Primary Care
article thumbnail

DASH Diet for Diabetes With Low Sodium Reduces BP in Those With Diabetes

Physician's Weekly

WEDNESDAY, June 18, 2025 (HealthDay News) — The Dietary Approaches to Stop Hypertension for Diabetes (DASH4D) diet with lower sodium is tied to clinically meaningful blood pressure reduction in people with diabetes, according to a study published online June 9 in JAMA Internal Medicine. Pilla, M.D., Pilla, M.D.,

article thumbnail

ADA: Orforglipron Reduces Glycated Hemoglobin in Early Type 2 Diabetes

Physician's Weekly

from the Velocity Clinical Research Center at Medical City Dallas, and colleagues conducted a phase 3 trial involving participants with type 2 diabetes treated only with diet and exercise, an HbA1c level of ≥7.0 Mild-to-moderate gastrointestinal events were the most common adverse events with orforglipron. Julio Rosenstock, M.D.,

article thumbnail

FDA Approves Polypill Widaplik for Hypertension

Physician's Weekly

The most common adverse event reported in patients treated with Widaplik was symptomatic low blood pressure. Widaplik is not to be coadministered with aliskiren in patients with diabetes, and a boxed warning indicates discontinuation of Widaplik during pregnancy.